{
  "article": {
    "id": "",
    "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832585/",
    "title": "Inter-agency perspective: Translating advances in biomarker discovery and medical countermeasures development between terrestrial and space radiation environments",
    "authors": [
      "Andrea L DiCarlo",
      "Lisa S Carnell",
      "Carmen I Rios",
      "Pataje G Prasanna"
    ],
    "journal": "",
    "year": "",
    "keywords": [
      "Space",
      "Radiation",
      "Medical countermeasures",
      "Chronic",
      "Cancer",
      "Biomarkers"
    ],
    "funding": [
      "NASA’s Biological and Physical Sciences Division",
      "NIAID’s RNCP",
      "NCI’s RRP"
    ],
    "abstract": "Over the past 20+ years, the U.S. Government has made significant strides in establishing research funding and initiating a portfolio consisting of subject matter experts on radiation-induced biological effects in normal tissues.",
    "sections": {
      "introduction": "Given the importance of ensuring the protection of humans from radiation injury, strong collaborations have been forged between U.S. Government funding agencies with mandates to develop products to protect, mitigate, and/or treat radiation-induced normal tissue injuries.",
      "methods": "",
      "results": "",
      "discussion": ""
    },
    "experimental_factors": {
      "organism": "",
      "cell_type": "",
      "tissue": "",
      "treatment": "radiation",
      "duration": "",
      "organism_raw": "",
      "cell_type_raw": "",
      "tissue_raw": "",
      "treatment_raw": "radiation",
      "duration_raw": "",
      "tissue_list": [],
      "treatment_list": [
        "radiation"
      ],
      "tissue_detail": [],
      "treatment_detail": [
        {
          "text": "radiation",
          "normalized": "radiation",
          "ontology": {
            "id": "",
            "label": ""
          }
        }
      ],
      "sex": "",
      "sex_raw": "",
      "sex_list": [],
      "genotype": "",
      "genotype_raw": "",
      "genotype_detail": {
        "text": "",
        "normalized": ""
      },
      "strain": "",
      "strain_raw": "",
      "line_name": "",
      "line_name_raw": "",
      "model_type": "",
      "model_type_raw": "",
      "age_at_sampling": "",
      "age_at_sampling_detail": {
        "raw": "",
        "normalized": "",
        "range": {
          "min": "",
          "max": ""
        }
      },
      "duration_detail": {
        "raw": "",
        "normalized": "",
        "range": {
          "min": "",
          "max": ""
        }
      },
      "cell_type_detail": {
        "text": "",
        "normalized": "",
        "ontology": {
          "id": "",
          "label": ""
        }
      }
    },
    "technologies": [],
    "technologies_detail": [],
    "insights_summary": "The U.S. Government has made significant strides in establishing research funding and initiating a portfolio consisting of subject matter experts on radiation-induced biological effects in normal tissues. The goal is to develop products to protect, mitigate, and/or treat radiation-induced normal tissue injuries. Collaboration between agencies is crucial to achieve this goal.",
    "acknowledgments": "",
    "references": []
  }
}